Studies that have utilized mice which lack either TLR2 or TLR4 suggest that, following an experimental stroke, increased TLR2 signaling enhances resistance to ischemic brain damage, whereas TLR4 activation aggravates the injurious effects of cerebral ischemia [65]–[67]. The gene discussed is TLR4; the disease is stroke disorder.